SCHEMBL17367485

SCHEMBL17367485

COc1cc(-c2sc(F)cc2C(C)=O)ccc1-c1ccc(C2(C(C)=O)CC2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.35
APP P05067 8/20 0.34
CYP2C19 P33261 5/20 0.34
CYP3A4 P08684 5/20 0.34
CYP2C9 P11712 5/20 0.34
CYP2D6 P10635 3/20 0.34
CYP1A2 P05177 1/20 0.34
AKR1C3 P42330 3/20 0.33
AKR1C2 P52895 3/20 0.33
AKR1C1 Q04828 2/20 0.33
AKR1B10 O60218 1/20 0.33
AKR1C4 P17516 1/20 0.33
PDE4A P27815 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
ITGA4 P13612 2/20 0.31
ITGB7 P26010 2/20 0.31
LMNA P02545 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ITGB1 P05556 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367491 0.93 APP (0.35) CHEK1APPCYP2C19CYP3A4CYP2C9
SCHEMBL17367484 0.84 APP (0.35) APPCYP2C19CYP3A4CYP2C9CYP2D6
SCHEMBL17367478 0.84 ALDH1A1 (0.42) CHEK1APPCYP2C19CYP3A4CYP2C9
SCHEMBL15853788 0.81 OPRM1 (0.40)
SCHEMBL17367488 0.80 CHEK1 (0.35) CHEK1APPCYP2C19CYP3A4CYP2C9
SCHEMBL15854042 0.79 APP (0.43) APPCYP2C19CYP3A4CYP2C9CYP2D6
SCHEMBL15853735 0.78 APP (0.44) APPCYP2C19CYP3A4CYP2C9CYP2D6
SCHEMBL15853737 0.78 APP (0.42) APPCYP2C19CYP3A4CYP2C9CYP2D6
SCHEMBL17215387 0.77 OPRM1 (0.37)
SCHEMBL17367434 0.76 LPAR1 (0.47) CYP2C9ITGA4ITGB7ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150376160-A1 HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND UBE INDUSTRIES, LTD. (JP) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376160-A1 HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND LPAR3, LPAR1, LPAR2 CHEK1 3087/4885APP 4316/4885CYP2C19 2055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.